Morris N. Teller
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Carcinogens and Genotoxicity Assessment
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- Cancer therapeutics and mechanisms 7
- Enzyme function and inhibition 5
- Phenothiazines and Benzothiazines Synthesis and Activities 3
-
- Synthesis and Biological Evaluation 4
- Synthesis and Characterization of Heterocyclic Compounds 3
- Structural and Chemical Analysis of Organic and Inorganic Compounds 3
- Co-authors
- George W. Woolley (8 shared papers)Christiane Stock (10 shared papers)Henryk Taper (1 shared paper)Michael P. Lardis (1 shared paper)Tadao Aoki (2 shared papers)George Bosworth Brown (7 shared papers)Richard J. Kaufman (3 shared papers)Kanematsu Sugiura (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (7 papers)Annals of the New York Academy of Sciences (2 papers)Experimental Biology and Medicine (1 paper)Tetrahedron (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Morris N. Teller
40 papers receiving 379 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 68
- Immunology 64
- Genetics 81
- Pharmaceutical Science 18
- Molecular Biology 188
Countries citing papers authored by Morris N. Teller
This map shows the geographic impact of Morris N. Teller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris N. Teller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris N. Teller more than expected).
Fields of papers citing papers by Morris N. Teller
This network shows the impact of papers produced by Morris N. Teller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris N. Teller. The network helps show where Morris N. Teller may publish in the future.
Co-authors
The 25 scholars most cited alongside Morris N. Teller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new transplantable mouse liver tumor of spontaneous origin. | 1966 | 77 |
| 2 | Biologic characteristics and chemotherapy of 7,12-dimethylbenz[a]anthracene-induced tumors in rats. | 1966 | 39 |
| 3 | 1964 | 37 | |
| 4 | A comparison of the oncogenicities of 3-hydroxyxanthine, guanine 3-N-oxide, and some related compounds. | 1970 | 33 |
| 5 | 1965 | 21 | |
| 6 | Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. | 1977 | 17 |
| 7 | Aging and cancerigenesis. 3. Effect of age on isoantibody formation. | 1966 | 17 |
| 8 | The use of transplantable human tumors in experimental chemotherapy. | 1958 | 15 |
| 9 | Studies on the oncogenicity of 3-hydroxyxanthine. | 1970 | 15 |
| 10 | Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. | 1969 | 15 |
| 11 | Effects of 17-alpha-thioestradiol, 2 estradiol analogs, and 2 androgens on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. | 1966 | 15 |
| 12 | 1967 | 12 | |
| 13 | Correlations between oncogenic and chemical properties of several derivatives of 3-hydroxyxanthine and 3-hydroxyguanine. | 1973 | 12 |
| 14 | 1965 | 12 | |
| 15 | 1978 | 11 | |
| 16 | Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system. | 1968 | 11 |
| 17 | 1958 | 8 | |
| 18 | Therapy of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2 alpha-methyldihydrotestosterone propionate. | 1982 | 8 |
| 19 | 1974 | 7 | |
| 20 | Comparison of the oncogenicities of four structurally isomeric N-hydroxyxanthines. | 1978 | 6 |
About Morris N. Teller
Morris N. Teller is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Genetics and Hematology, having authored 41 papers that have together received 452 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Estrogen and related hormone effects (5 papers), Multiple Myeloma Research and Treatments (5 papers), Enzyme function and inhibition (5 papers), Synthesis and Biological Evaluation (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Structural and Chemical Analysis of Organic and Inorganic Compounds (3 papers). The work is most often cited by research in Cancer Research (68 citations), Immunology (64 citations), Genetics (81 citations), Pharmaceutical Science (18 citations) and Molecular Biology (188 citations). Morris N. Teller has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include George W. Woolley, Christiane Stock, Henryk Taper, Michael P. Lardis, Tadao Aoki, George Bosworth Brown, Richard J. Kaufman, Kanematsu Sugiura, Joy Palm and David Curtis. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Annals of the New York Academy of Sciences, Experimental Biology and Medicine, Tetrahedron and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.